FDA recall Z-1301-2018

The Binding Site Group, Ltd. · Class II · device

Product

Binding Site Optilite Beta-2-Microglobulin Urine Kit, Ref LK043.L.OPT.A, IVD. The firm name on the label is The Binding Site Group Ltd., Birmingham, U.K. The Optilite Beta-2-Microglobulin (¿2M) Urine kit is intended for the quantitative in-vitro measurement of beta-2-microglobulin in urine using the Binding Site Optilite analyser to aid in the diagnosis of active rheumatoid arthritis and kidney disease. This test should be used in conjunction with other laboratory and clinical findings.

Reason for recall

The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.

Distribution

US Distribution was made to CA. There was no foreign/military/government distribution.

Key facts

Status
Terminated
Initiation date
2018-03-09
Report date
2018-04-11
Termination date
2020-06-22
Voluntary/Mandated
Voluntary: Firm initiated
Location
Birmingham, N/A, United Kingdom

Primary source

https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1301-2018